23 related articles for article (PubMed ID: 19701832)
1. Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors.
Arai M; Hanada M; Moriyama H; Ohmoto H; Miyake T; Naka K; Sawa M
Bioorg Med Chem Lett; 2024 Aug; 108():129797. PubMed ID: 38759932
[TBL] [Abstract][Full Text] [Related]
2. Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors.
Daldrup-Link HE; Mohanty S; Ansari C; Lenkov O; Shaw A; Ito K; Hong SH; Hoffmann M; Pisani L; Boudreau N; Gambhir SS; Coussens LM
JCI Insight; 2016 May; 1(6):. PubMed ID: 27182558
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenetic Protein-4 (BMP4): A Paracrine Regulator of Human Adrenal C19 Steroid Synthesis.
Rege J; Nishimoto HK; Nishimoto K; Rodgers RJ; Auchus RJ; Rainey WE
Endocrinology; 2015 Jul; 156(7):2530-40. PubMed ID: 25868050
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.
Tee MK; Huang N; Damm I; Miller WL
Mol Endocrinol; 2011 May; 25(5):715-31. PubMed ID: 21393444
[TBL] [Abstract][Full Text] [Related]
5. The interplay between bioactive sphingolipids and steroid hormones.
Lucki NC; Sewer MB
Steroids; 2010 Jun; 75(6):390-9. PubMed ID: 20138078
[TBL] [Abstract][Full Text] [Related]
6. Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors.
Mansour MA; Hassan GS; Serya RAT; Jaballah MY; Abouzid KAM
Bioorg Chem; 2024 Jun; 147():107332. PubMed ID: 38581966
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP17 expression by adrenal androgens and transforming growth factor beta in adrenocortical cells.
Biernacka-Łukanty JM; Lehmann TP; Trzeciak WH
Acta Biochim Pol; 2004; 51(4):907-17. PubMed ID: 15625562
[TBL] [Abstract][Full Text] [Related]
9. SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Mol Cell Biochem; 2008 Jan; 307(1-2):65-71. PubMed ID: 17786540
[TBL] [Abstract][Full Text] [Related]
10. Vitreous induces heme oxygenase-1 expression mediated by transforming growth factor-beta and reactive oxygen species generation in human retinal pigment epithelial cells.
Hartung R; Parapuram SK; Ganti R; Hunt DM; Chalam KV; Hunt RC
Mol Vis; 2007 Jan; 13():66-78. PubMed ID: 17277740
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
Derebecka-Holysz N; Lehmann TP; Holysz M; Trzeciak WH
Endocr Res; 2009; 34(3):68-79. PubMed ID: 19701832
[TBL] [Abstract][Full Text] [Related]
13. Activin receptor-like kinases: structure, function and clinical implications.
Graham H; Peng C
Endocr Metab Immune Disord Drug Targets; 2006 Mar; 6(1):45-58. PubMed ID: 16611164
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
